Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000374:Aggression / Q000187:drug effects; D001712:Biperiden / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003989:Dibenzoxazepines / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D008152:Loxapine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011595:Psychomotor Agitation / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy*; D012890:Sleep / Q000187:drug effects; D014851:Wakefulness
D003989:Dibenzoxazepines; D001712:Biperiden; D006220:Haloperidol; D008152:Loxapine